Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures (NCT06534502)
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Zonisamide Oral Suspension (100 mg/5 ml) to Determine a Dosing Regimen in Children 1 Month to 17 Years of Age With Partial-onset Seizures
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research is to determine the optimal dose, safety and tolerability of zonisamide oral suspension in children ages 1 month to 17 years of age who have partial-onset (focal) seizures. The study consists of four periods: a Screening Period (about 14 days), a Titration Period (8 weeks), a Maintenance Period (4 weeks), and a Follow-Up Period (1 week).
Who can join: Review the eligibility criteria below.
Location: Wake Forest University School of Medicine — Winston-Salem, North Carolina
Age range: 1 Month to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Wake Forest University School of Medicine — Winston-Salem, North Carolina
- Le Bonheur Children's Hospital — Memphis, Tennessee
📞 Contact the Study Coordinator
Phone: (800) 461-7449
Email: dfreedman@azurity.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Seizures
- Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients — New Haven, Connecticut
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults — Palo Alto, California
- Modulating Movement Intention Via Cortical Stimulation — New York, New York
- Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy — Gainesville, Florida
- Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases — Boston, Massachusetts
Explore by condition: All Seizures clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.